FOXO Technologies Inc.

FOXO

US3514713052

IT Services & Consulting

Market Closed - Nyse Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
0.2628 ^USD	-2.01%		+7.35%	-17.80%

17/06	FOXO Technologies Inc. agreed to acquire Rennova Community Health, Inc. from Rennova Health, Inc.(OTCPK:RNVA) for $20 million.	CI
14/06	Sector Update: Health Care Stocks Decrease Late Afternoon	MT

FOXO Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

June 07, 2024 at 01:45 am IST

FOXO Technologies Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.145 million compared to USD 0.511 million a year ago. Net loss was USD 26.45 million compared to USD 95.26 million a year ago.

Basic loss per share from continuing operations was USD 7.08 compared to USD 84 a year ago.

Latest news about FOXO Technologies Inc.

FOXO Technologies Inc. agreed to acquire Rennova Community Health, Inc. from Rennova Health, Inc.(OTCPK:RNVA) for $20 million.	17/06	CI
Sector Update: Health Care Stocks Decrease Late Afternoon	15/06	MT
Sector Update: Health Care Stocks Softer Friday Afternoon	14/06	MT
Sector Update: Health Care	14/06	MT
FOXO Technologies Shares Jump After Signing Share Exchange Deals to Acquire Rennova Health's Healthcare Operations	14/06	MT
FOXO Technologies Inc. completed the acquisition of Myrtle Recovery Centers, Inc from Rennova Health, Inc..	14/06	CI
FOXO Technologies Inc. entered into the Stock Exchange Agreement to acquire Myrtle Recovery Centers, Inc from Rennova Health, Inc. for $0.5 million.	13/06	CI
FOXO Technologies Inc. announced that it expects to receive $2.8 million in funding	12/06	CI
FOXO Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/06	CI
FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC	28/04	CI
Sector Update: Tech Stocks Higher Premarket Wednesday	24/04	MT
FOXO Technologies Gets Non-Compliance Notice From NYSE American	24/04	MT
FOXO Technologies Inc. announced that it has received $0.1422 million in funding	20/03	CI
FOXO Technologies Inc. announced that it expects to receive $0.1422 million in funding	05/03	CI
FOXO Technologies Inc. entered into a non-binding agreement to acquire M2i Global, Inc..	14/02	CI
FOXO Technologies Inc. announced that it has received $0.45747 million in funding	12/02	CI
FOXO Technologies Shares Jump After Interim CEO Discloses Stake	05/02	MT
FOXO Technologies Inc. Announces Appointment of Francis Colt Dewolf to the Board of Directors	26/01	CI
Wall Street Set to Open Higher in Monday Trading Ahead of Economic Indicators Data	22/01	MT
FOXO Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/01	CI
FOXO Technologies Inc. announced that it expects to receive $0.45747 million in funding	19/01	CI
FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors	28/11	CI
FOXO Technologies Inc. Plans to Unveil its New Direct-To-Consumer App, the VITHAR? AI Health Coach	08/11	CI
FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai	30/23/30	CI
North American Morning Briefing : Rate Decisions, Jobs Data Headline a Busy Week	30/23/30	DJ

Chart FOXO Technologies Inc.

Duration

Period

More charts

Company Profile

FOXO Technologies Inc. is a biotechnology company. The Company is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The Company operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.

Sector

IT Services & Consulting

Calendar

11/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other IT Services & Consulting

	1st Jan change	Capi.
FOXO TECHNOLOGIES INC.	-17.80%	2.94M
ACCENTURE PLC	-12.46%	192B
TATA CONSULTANCY SERVICES LTD.	+1.65%	166B
IBM	+5.53%	159B
AUTOMATIC DATA PROCESSING, INC.	+6.62%	102B
CROWDSTRIKE HOLDINGS, INC.	+51.48%	94.12B
RELX PLC	+16.91%	85.34B
INFOSYS LIMITED	-0.03%	76.53B
HCL TECHNOLOGIES LIMITED	-1.69%	47B
SNOWFLAKE INC.	-37.58%	41.59B